Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hung-Cheng Kan is a pioneering urologic surgeon and researcher whose work is reshaping the surgical management of urologic cancers, with a particular focus on robotic-assisted and minimally invasive techniques. His primary research areas include robot-assisted partial nephrectomy, adrenalectomy, and radical prostatectomy, where he has made significant contributions to improving surgical precision and patient outcomes. Dr. Kan’s landmark 2022 study on indocyanine green fluorescence in robot-assisted partial nephrectomy (18 citations) demonstrated the clinical benefits of real-time intraoperative imaging, enhancing tumor resection accuracy while preserving healthy renal tissue. He has also been at the forefront of advancing laparoendoscopic single-site surgery, as evidenced by his work on robot-assisted adrenalectomy (14 citations). Demonstrating remarkable innovation, Dr. Kan is integrating artificial intelligence into postoperative care; his 2023 study (8 citations) used deep learning to predict recovery from postprostatectomy urinary incontinence from cystography images, offering a rapid, objective tool for functional outcome prediction. His research on periprostatic adipose tissue (2024) further reveals novel insights into the tumor microenvironment’s role in prostate cancer progression. With a growing citation impact and a portfolio that bridges surgical innovation, AI, and tumor biology, Dr. Kan is a leading voice in modern urologic oncology.